GV (Google Ventures)

Activity from announced rounds

Activity in this selectionUnited States · May 31, 2026 · May 1, 2026

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$56M
3 disclosed · full round size, not this investor’s share

By stage

Growth1
Seed1
Series A1

By primary sector

AI1
Enterprise software1
Healthtech1

By country

United States3

Rounds

3 in this selection
Signos, Inc.

Offers an FDA-cleared AI-powered glucose monitoring system for weight management and metabolic health

$20MGrowth
Role not disclosed
Flick

AI-native filmmaking platform giving creators cinematic control to direct AI-generated films

$6MSeed
Role not disclosed
Nectar Social

Provides AI infrastructure for modern marketing

$30MSeries A
Role not disclosed